alt=Stryker Roll-In-Stretcher|Stryker Roll-In-Stretcher|thumb
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology (60% of 2024 revenues), which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery (40% of 2024 revenues), which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. and 331st on the Forbes Global 2000.
History
In 1941, The Orthopedic Frame Company was founded by Homer Stryker, an orthopedist from Kalamazoo, Michigan.
In 1977, John W. Brown joined as president and CEO and became chairman in 1981. He transitioned to chairman in 2003. In 2009, Brown retired as chairman after 32 years with the company. Under his leadership, revenues rose from $17 million to $6.7 billion.
In 1979, Stryker became a public company via an initial public offering. The second, sent November 2007, cited issues at the firm's Mahwah, New Jersey, facility, including poor fixation of hip implant components, in some instances requiring mitigation by revision surgeries; exceeded microbial level violations in the cleaning and final packaging areas of the sterile implants; and failure to institute measures in prevention of recurrence of these and other problems. The third warning letter, sent April 2008, cited issues at the firm's biotechnology facility in Hopkinton, Massachusetts related to quality and noncompliance including falsification of documents relevant to the selling of products to hospitals which are to be sold under a limited, government-mandated basis. Stryker maintains that employees involved in the falsification of documents have since been terminated.
In August 2010, the company paid $1.35 million to settle claims that it marketed items without regulatory approval and misled health care providers about the use of its products.
Stryker initiated a product recall on several models of medical vacuums sold under the Neptune Waste Management System brand in June and September 2012. The devices, some of which had not been cleared by the Food and Drug Administration, caused a fatal accident when the vacuum was mistakenly used to suction a passive drainage tube.
In 2012, the FDA issued a warning for the Stryker Rejuvenate hip replacement after it was discovered that the hip replacement was considered defective and could cause similar side effects to DePuy Synthes hip implants. As a result, in 2014, Stryker was fined $1 billion and $2.5 billion, respectively, for its defective Rejuvenate and ABG II hip replacements that can cause excruciating pain.
In February 2012, MacMillan resigned and Curt R. Hartman was named interim chief executive officer, vice-president and chief financial officer. William U. Parfet was named non-executive chairman of the board. In October 2012, Kevin A. Lobo was appointed as president and chief executive officer.
In 2013, the company agreed to pay $13.2 million to settle charges that it made illicit payments totaling approximately $2.2 million in Argentina, Greece, Mexico, Poland, and Romania. In 2018, the company was fined $7.8 million under the Foreign Corrupt Practices Act for failing to detect the risk of improper payments in sales of products in India, China, and Kuwait.
In 2016, subsidiary company Stryker EMEA Supply Chain Services BV challenged the Dutch authorities' interpretation of procurement nomenclature regarding implant screws intended to be inserted in the human body. The matter was referred to the European Court of Justice for a preliminary ruling on the legal position and on the validity of the relevant EU implementing regulation.
Stryker is among companies that continue business-as-usual in Russia during the 2022 Russian invasion of Ukraine despite international sanctions during the Russian invasion of Ukraine. Research from Yale School of Management evaluating companies' reaction to the Russian invasion put Stryker in the "Grade F" category of "Digging In", meaning "Defying Demands for Exit or Reduction of Activities."
In 2023, Stryker introduced a minimally invasive bunion treatment system, Prostep MIS Lapidus, which aims to reduce bunion recurrence, minimize scarring, and lower opioid use.
On 11 March 2026, during the 2026 Iran war, the Handala Hack Team issued a remote wipe of company computers using Microsoft Intune. This attack was reported to delay surgeries for some patients. In the first week of April, Stryker reported to be fully operational again.
{| class="wikitable sortable"
|+Acquisitions
|-
! scope="col" | Date
! scope="col" | Company
! scope="col" data-sort-type="number" | Value
! scope="col" class="unsortable" | Description
! scope="col" class="unsortable" | References
|-
|
| Osteonics
|
| Entrance to the replacement hip, knee, and other orthopedic implants market
|
|-
|
| Guided Technologies
|
| Developer and manufacturer of optical localizers
|
|-
|
| Spinal Implant Business of Surgical Dynamics
| data-sort-value="135" | $135 million
|
|
|-
|
| SpineCore
| data-sort-value="120" | $120 million
| Development of artificial spinal disks
|
|-
|
| eTrauma.com
| data-sort-value="50" | $50 million
| Development of software for Picture archiving and communication system (PACS)
|
|-
|
| Sightline Technologies
| data-sort-value="50" | $50 million
| Manufacturer of gastrointestinal endoscopy apparatuses; partially closed in 2008
|
|-
|
| PlasmaSol
| data-sort-value="17.5" | $17.5 million
| Technologies allowing sterilization of various MedSurg equipments
|
|-
|
| Ascent Healthcare Solutions
| data-sort-value="525" | $525 million
| Reprocessing and remanufacturing of medical devices in the United States
|
|-
|
| Neurovascular Division of Boston Scientific
| data-sort-value="1500" | $1.5 billion
| Products used for the minimally invasive treatment of hemorrhagic and ischemic stroke
|
|-
|
| Orthovita
|
| A biomaterials company specializing in bone augmentation and substitution technologies.
|
|-
|
| Memometal Technologies
| data-sort-value="162" | $162 million
| Manufactures and markets products for extremity indications based on its proprietary methods for preparing and manufacturing a shape memory metal alloy
|
|-
|
| Concentric Medical
| data-sort-value="135" | $135 million
| Devices for the removal of thrombus in patients experiencing acute ischemic stroke along with a broad range of AIS access products
|
|-
|
| Surpass Medical
| data-sort-value="135" | $135 million
| Flow diversion stent technology to treat brain aneurysms using a mesh design and delivery system
|
|-
|
| Trauson Holdings
| data-sort-value="764" | $764 million
| Trauma manufacturer in China
|
|-
|
| MAKO Surgical Corp.
| data-sort-value="1650" | $1.65 billion
| Surgical robotic arm assistance platforms, most notably the RIO (Robotic Arm Interactive Orthopedic System) as well as orthopedic implants used by orthopedic surgeons for use in partial knee and total hip arthroplasty
|
|-
|
| Patient Safety Technologies
| data-sort-value="85" | $85 million
| Safety-Sponge System, an integrated counting and documentation system that prevents surgical sponges and towels from being unintentionally left in patients after surgical procedures
|
|-
|
| Pivot Medical
|
| Products for hip arthroscopy
|
|-
|
| Berchtold Holding AG
| data-sort-value="172" | $172 million
| Surgical tables, equipment booms, and surgical lighting systems
|
|-
|
| Small Bone Innovations
| data-sort-value="358" | $358 million
| Products that help surgeons treat and replace small bones and joints
|
|-
|
| Muka Metal
|
| Manufactures hospital beds and patient furniture in Kayseri, Turkey
|
|-
|
| Sage Products
| data-sort-value="2780" | $2.78 billion
| Disposable device maker
|
|-
|
| Physio-Control
| data-sort-value="1280" | $1.28 billion
| Maker of defibrillators
|
|-
|
| Arthrogenx
|
| Cobra reusable suture passer for arthroscopic rotator cuff repair
|
|-
|
| Novadaq
| data-sort-value="701" | $701 million
| Fluorescence imaging systems
|
|-
|
| Vexim
| data-sort-value="183" | €183 million
| Minimally invasive treatment of vertebral fractures
|
|-
|
| Entellus Medical
| data-sort-value="662" | $662 million
| Minimally invasive products for the treatment of various ENT diseases
|
|-
|
| Hygia Health Services
|
| Reprocessing of patient care single-use devices
|
|-
|
| SafeAir AG
|
| Surgical smoke evacuation
|
|-
|
| Invuity
| data-sort-value="190" | $190 million
| Surgical lighting company
|
|-
|
| HyperBranch Medical Technology
| data-sort-value="220" | $220 million
| Maker of Adherus AutoSpray dural sealant
|
|-
|
| K2M Group Holdings
| data-sort-value="1400" | $1.4 billion
| Spinal surgery device-maker
|
|-
|
| Arrinex
|
| Manufacturer of cryoablation technology for the treatment of chronic rhinitis
|
|-
|
| OrthoSpace
| data-sort-value="220" | $220 million
| Rotator cuff implant
|
|-
|
| Mobius Imaging and GYS Tech
| data-sort-value="370" | $370 million
| Intra-operative imaging; plus up to $130 million in contingent payments
|
|-
|
| Wright Medical Group
| data-sort-value="5400" | $5.4 billion
| Upper-body implants
|
|-
|
| OrthoSensor
|
| Sensor technology for use in total joint replacement procedures
|
|-
|
| TMJ Concepts
|
| Patient-specific implants for TMJ reconstruction
|
|-
|
| Gauss Surgical
|
| Platform for real-time monitoring of blood loss during surgery
|
|-
|
| Vocera Communications
| data-sort-value="2970" | $2.97 billion
| Digital patient-outreach tools
|
|-
|
| SERF SAS
|
| Joint replacements
|
|-
|
| Care.ai
|
| Artificial intelligence-based tools for hospitals
|
|-
|
| NICO Corporation
|
| Minimally invasive solutions for brain tumor removal and stroke care
|
|-
|
| Inari Medical
| data-sort-value="4900" | $4.9 billion
| Catheter-based mechanical thrombectomy systems to treat vascular disease
|
|}